Chief Financial Officer

Chief Commercial Officer

Roth starts ARS Pharmaceuticals at Buy, sees 'vast improvement' from Neffy

Anaphylaxis Market to Reach USD 3.9 Bn by 2035, Expanding at a CAGR of 5.9% | Transparency Market Research, Inc.

ARS Pharmaceuticals initiated with bullish view at Roth Capital

Regeneron’s Antibodies Block Cat and Birch Allergies With ‘Robust Activity’

Specialty Sales Representative

ARS Pharmaceuticals is a fast growing and innovative company committed to improving patient outcomes through novel products. The Specialty Sales Representative will be responsible for driving brand recognition and adoption, engaging with healthcare providers and stakeholders to establish business relationships and facilitate product adoption within assigned accounts.

Sign up with Google

Sign in with Google